SomaLogic goes public, will trade on Nasdaq

BOULDER — Two weeks after Boulder biosciences company SomaLogic Inc. won U.S. Securities and Exchange Commission approval for its go-public merger with a special purpose acquisition company, shareholders signed off on the move Tuesday and set the stage for the company’s stock to begin trading on the Nasdaq exchange.

SomaLogic,  which develops platforms to read thousands of proteins in a patient’s blood or urine sample that may signal illnesses or future health conditions and suggest potential treatments via machine learning, will begin trading publicly under the ticker symbol SLGC on Thursday. 

“We are both excited and prepared to begin a new…